Michael J Jackson Selected Research

1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)

4/2018	The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease.
1/2017	Magnetic resonance imaging and tensor-based morphometry in the MPTP non-human primate model of Parkinson's disease.
1/2017	Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia.
1/2016	Oral r-(-)-11-o-valeryl-n-n-propylnoraporphine reverses motor deficits in mptp-treated marmosets.
2/2014	Proteomic analysis of striatum from MPTP-treated marmosets (Callithrix jacchus) with L-DOPA-induced dyskinesia of differing severity.
12/2010	Morphological changes in serotoninergic neurites in the striatum and globus pallidus in levodopa primed MPTP treated common marmosets with dyskinesia.
2/2010	Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets.
12/2007	The administration of entacapone prevents L-dopa-induced dyskinesia when added to dopamine agonist therapy in MPTP-treated primates.
4/2007	Antiparkinsonian activity of L-propyl-L-leucyl-glycinamide or melanocyte-inhibiting factor in MPTP-treated common marmosets.
3/2007	Decreased expression of l-dopa-induced dyskinesia by switching to ropinirole in MPTP-treated common marmosets.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael J Jackson Research Topics

Disease

22	Dyskinesias (Dyskinesia) 01/2020 - 09/2002
19	Parkinson Disease (Parkinson's Disease) 01/2020 - 09/2002
4	Chorea (Rheumatic Chorea) 12/2006 - 09/2002
3	Dystonia (Limb Dystonia) 12/2006 - 10/2003
1	Inflammation (Inflammations) 01/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Abnormal Reflex (Hyperreflexia) 01/2017
1	Hypertrophy 12/2010
1	Parkinsonian Disorders (Parkinsonism) 12/2006
1	Multiple System Atrophy 11/2006
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2006
1	Mental Disorders (Mental Disorder) 11/2004
1	Hyperkinesis 09/2002

Drug/Important Bio-Agent (IBA)

24	Levodopa (L Dopa)FDA LinkGeneric 01/2020 - 09/2002
22	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2018 - 09/2002
8	Dopamine Agonists (Dopamine Agonist)IBA 01/2016 - 09/2002
6	Dopamine (Intropin)FDA LinkGeneric 01/2020 - 09/2002
6	Pharmaceutical PreparationsIBA 12/2007 - 09/2002
3	BenserazideIBA 04/2012 - 04/2007
3	Serotonin (5 Hydroxytryptamine)IBA 12/2010 - 10/2003
3	Carbidopa (Lodosyn)FDA LinkGeneric 06/2010 - 03/2005
3	Pramipexole (Mirapex)FDA LinkGeneric 02/2010 - 10/2003
3	entacapone (Comtan)FDA Link 12/2007 - 05/2003
2	Apomorphine FDA Link 01/2016 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 02/2014 - 11/2006
2	ropinirole (Requip)FDA LinkGeneric 12/2007 - 03/2007
2	Dopamine Receptors (Dopamine Receptor)IBA 03/2007 - 09/2002
2	Piribedil (Trivastal)IBA 05/2006 - 09/2002
2	PiperazineIBA 09/2002 - 09/2002
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2021
1	Carbachol (Carbastat)FDA Link 01/2021
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 01/2021
1	SynucleinsIBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020
1	5-HT1A Serotonin ReceptorIBA 01/2020
1	befiradolIBA 01/2020
1	Harmine (Telepathine)IBA 04/2018
1	Selegiline (E250)FDA LinkGeneric 04/2018
1	11-hydroxy-N-(n-propyl)noraporphineIBA 01/2016
1	ValeratesIBA 01/2016
1	Peptides (Polypeptides)IBA 02/2014
1	Aromatic-L-Amino-Acid DecarboxylasesIBA 04/2012
1	Tryptophan HydroxylaseIBA 12/2010
1	Oxidopamine (6 Hydroxydopamine)IBA 12/2010
1	Dopa DecarboxylaseIBA 06/2010
1	Aromatic Amino Acid Decarboxylase InhibitorsIBA 06/2010
1	catechol (pyrocatechol)IBA 12/2007
1	NeuropeptidesIBA 04/2007
1	glycine amideIBA 04/2007
1	tandospironeIBA 12/2006
1	sarizotanIBA 12/2006
1	tetralinIBA 12/2006
1	OsteopontinIBA 11/2006
1	2- n- butyl- 9- methyl- 8- (1,2,3)triazol- 2- yl- 9H- purin- 6- ylamineIBA 09/2006
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 09/2006
1	Haloperidol (Haldol)FDA LinkGeneric 11/2004
1	5-HT1B Serotonin ReceptorIBA 11/2004
1	Antipsychotic Agents (Antipsychotics)IBA 11/2004
1	inulin trinicotinate monomethochloride (L-3)IBA 11/2004
1	BTS 74 398IBA 01/2004
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2003
1	Pergolide (Permax)FDA Link 01/2003
1	vanoxerine (I 893)IBA 09/2002
1	brasofensineIBA 09/2002
1	Dopamine Agents (Dopaminergic Agents)IBA 09/2002

Therapy/Procedure

3	Therapeutics 01/2016 - 01/2003
2	Oral Administration 01/2016 - 05/2006
1	Drug Therapy (Chemotherapy) 01/2020
1	Subcutaneous Injections 01/2016
1	Subcutaneous Infusions 01/2016
1	Pallidotomy 09/2005